NEW YORK (GenomeWeb News) – Adaptive Biotechnologies today announced it raised $105 million in private funding, which will allow it to expand its immunosequencing research platform and clinical diagnostic products.
NEW YORK (GenomeWeb News) – Adaptive Biotechnologies today said that it has received a $2.53 million Phase II Small Business Innovation Research grant to support its adaptive immune system testing technology.
NEW YORK (GenomeWeb News) – Sequenta has gained the exclusive rights to iRepertoire's IP related to methods of immune cell sequencing for minimal residual disease testing, the two companies said today.
NEW YORK (GenomeWeb News) – A team at the Fred Hutchinson Cancer Research Center has won $4.4 million in funding from the National Cancer Institute to use RNA sequencing to study proteins that may be involved in the body's immune response to cancer, the center said on Monday.
NEW YORK (GenomeWeb News) – A Rockefeller University researcher plans to use a $1.3 million grant from the National Institutes of Health to develop a novel method for applying high-throughput sequencing to the study of human immune system function.
NEW YORK (GenomeWeb News) – Atreca today announced it has licensed immune repertoire capture technology from Stanford University, which the biopharmaceutical company will develop for a broad range of applications.